Link to Medical and Epidemiological working site for subcommittee members only

Chair: Paul Wambach (+1-301-903-7373, paul.wambach@hq.doe.gov )

The Medical/Epidemiological Subcommittee follows beryllium medical, epidemiological
and toxicological research; studies of workforces exposed to beryllium; and
developments in screening and diagnostic tests for beryllium sensitization and CBD. The
subcommittee serves as a forum for discussion among occupational medical directors
and
allied personnel on topics including, but not limited to, the following:

• Beryllium carcinogenicity
• Relationship, if any, of exposure to response
• Pros and cons of early diagnosis
• Removal of sensitized personnel from further beryllium exposure
  

The subcommittee seeks to identify medical/epidemiological research needs and to
advertise those needs via the BHSC Research Needs list and other venues. The
subcommittee also seeks to promote a consistent approach across member sites.

.gov)

The Medical/Epidemiological Subcommittee follows beryllium medical, epidemiological
and toxicological research; studies of workforces exposed to beryllium; and
developments in screening and diagnostic tests for beryllium sensitization and CBD. The
subcommittee serves as a forum for discussion among occupational medical directors and
allied personnel on topics including, but not limited to, the following:

• Beryllium carcinogenicity
• Relationship, if any, of exposure to response
• Pros and cons of early diagnosis
• Removal of sensitized personnel from further beryllium exposure
  

The subcommittee seeks to identify medical/epidemiological research needs and to
advertise those needs via the BHSC Research Needs list and other venues. The
subcommittee also seeks to promote a consistent approach across member sites.